Inhalable Measles Vaccine Seen as Treatment Boon
Aktiv-Dry was featured on CBS news. Please click the link below to see the article.
CBS News - Inhalable Measles Article
Aktiv-Dry Selected for a $19.5 Million Grant from the Foundation for the National Institutes of Health
Aktiv-Dry Awarded Research Grant to Explore Inhalable siRNA Dry Powder Targeting RSV
New York Times report on the Grand Challenges in Global Health Initiative.
NY Times December 6, 2005, D. McNeil Jr.